From bioworld.com
AI cancer firm Oncocross debuts with $60M IPO on Kosdaq
2 2
AI-powered drug R&D platform firm Oncocross Co. Ltd. is leading the procession of year-end Korea biotech IPOs this week, pricing an offering of about 11.85 million shares on the Korea Exchange at ₩7,300 each for gross proceeds of ₩85.56 billion (US$59.5 million).
#ipo #doctor #kosdaq #medtech #hospital #medicine #medgadget #oncocross #healthcare #healthtech
10h ago
The National Psychologist | online newspaper for psychologist
32 203
The National Psychologist is an online news and information source designed for practicing psychologists and mental health workers wanting to keep up with their profession. Topics include legal and legislative issues, ethics, risk management, cyberspace for psychologists, book reviews, and more....
#bd #apa #cdp #ipo #sec #mrna #aetos #proen #alaris #kosdaq
on Oct 27, 2023
From bioworld.com
BioWorld MedTech: The Daily Medical Technology News Source
10 45
Daily news and analysis of the medical technology industry. In-depth coverage of business, financing, regulation, science, innovation, device approvals, clinical trials and more.
#bd #ipo #sec #mrna #aetos #proen #alaris #kosdaq #labcorp #obesity
on Jul 15